Table 2.
TNF-α | IL-1β | M-CSF | C5/C5a | IL-4 | IL-10 | sICAM-1 | TIMP-1 | IL-1α | IL-1ra | |
---|---|---|---|---|---|---|---|---|---|---|
Coordinate | D3 | A10 | C4 | A2 | B2 | B6 | A7 | D2 | A9 | A11 |
MRcko | ||||||||||
mdx 4WK QUAD | +++ | +++ | ↑2.8× | ↑1.2× | +++ | +++ | ↓1% | ↑1.2× | +++ | ↓6% |
mdx 4WK DIA | ↓20% | ↓64% | ↓10% | ↓1% | ↓45% | ↓50% | === | === | ↓50% | ↓11% |
WT AID4 TA | ↑1.6× | N.D. | ↑1.3× | ↑1.1× | N.D. | N.D. | === | ↑1.1× | N.D. | === |
Quantification of relative cytokine levels detected in myeloid mineralocorticoid receptor knockout (MRcko) mdx and injured MRcko wild-type (WT) skeletal muscle by pixel densitometry. Results are displayed as fold increases and % decreases in MRcko skeletal muscle relative to the appropriate Cre− controls. Coordinates listed in the table correspond to the individual chemokine’s location (in duplicate) on the immunoblot. Some quantified cytokines were equivalent (===) or not detected (N.D.) compared with Cre− controls. Other cytokines were upregulated (+++) but, however, undetected in Cre− controls and therefore excluded from quantification. AID4, 4 days after acute injury; DIA, diaphragm; M-CSF, macrophage colony-stimulating factor; QUAD, quadriceps; sICAM-1, soluble ICAM-1; TA, tibialis anterior; TIMP-1, tissue inhibitor of metalloproteinase-1; 4WK, 4 wk of age.